Key Takeaways:Bioniq has been acquired by Herbalife in a deal valued at up to $150 million.The purchase price is $55 million with an additional $95 million of contingent payments pending future performance.Bioniq creates personalized supplements based on blood biomarker analysis.Herbalife will expand its personalized nutritional supplement capabilities through a planned acquisition of Bioniq.WHO: London-based personalized supplement Bioniq was launched in 2019 by former German national basketball team player Vadim Fedotov. The business develops personalized supplement formulas using its patented product personalization engine, an individual’s health background, and a proprietary database of biomarkers. Bioniq’s personalized supplement formulations are designed for a broad range of individuals, from everyday wellness consumers to elite athletes, including Cristiano Ronaldo. Bioniq has built one of the largest proprietary datasets in the category, comprising over 6 million data points collected across 70 markets worldwide, including the United States, Europe, and the Middle East.Founded in 1980, Herbalife is a premier health and wellness company, community, and platform. The company offers science-backed products to consumers in more than 90 markets through entrepreneurial distributors who provide one-on-one coaching, and a supportive community that inspires their customers to embrace a healthier, more active lifestyle to live their best life.WHY: The transaction advances Herbalife’s vision of becoming a technology-enabled, data-driven health and wellness platform.